[Interactions of antirheumatic agents].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004347:Drug Interactions; D005938:Glucocorticoids / Q000494:pharmacology; D006046:Gold / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D010396:Penicillamine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000964:Antimetabolites, Antineoplastic; D004232:Diuretics; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D006046:Gold; D002738:Chloroquine; D010653:Phenylbutazone; D010396:Penicillamine; D001241:Aspirin
Interaktionen antirheumatisch wirksamer Substanzen.